Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Konstantopoulos N, Molero JC, McGee SL, Spolding B, Connor T, de Vries M, Wanyonyi S, Fahey R, Morrison S, Swinton C, Jones S, Cooper A, Garcia-Guerra L, Foletta VC, Krippner G, Andrikopoulos S, Walder KR.
Konstantopoulos N, et al. Among authors: foletta vc.
Diabetes. 2012 Aug;61(8):2146-54. doi: 10.2337/db11-0578. Epub 2012 May 14.
Diabetes. 2012.
PMID: 22586591
Free PMC article.